Acquirer · Corporate
AstraZeneca
1Undisclosed—0
Photo: Ajay Kumar Chaurasiya / Wikimedia Commons, CC BY-SA 4.0AstraZeneca acquires St. Louis vaccine startup Omniose after three-year research partnership
The drugmaker already had exclusive rights to Omniose's single-cell bioconjugation platform through a 2024 collaboration. Now it owns the company outright and has folded it into its infectious disease unit.
Undisclosedn/aStage n/aCorporate
Latest in AstraZeneca
All AstraZeneca exitsOpen tracker →
AstraZeneca → OmnioseUndisclosedUndisclosed